These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3977332)

  • 1. Metabolic importance of acanthosis nigricans.
    Flier JS
    Arch Dermatol; 1985 Feb; 121(2):193-4. PubMed ID: 3977332
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin receptors in syndromes involving acanthosis nigricans and severe insulin resistance].
    Muggeo M; Businaro V; Faronato PP; Moghetti P; Valerio A; Cardin-de' Stefani E; Chieregato GC
    G Ital Dermatol Venereol; 1982; 117(2):73-82. PubMed ID: 6764907
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-resistant diabetes mellitus and insulin receptor antibodies: variable association with acanthosis nigricans.
    Goldman J
    Henry Ford Hosp Med J; 1980; 28(2-3):161-7. PubMed ID: 7287512
    [No Abstract]   [Full Text] [Related]  

  • 4. Acanthosis nigricans and insulin resistance associated with hypothyroidism.
    Ober KP
    Arch Dermatol; 1985 Feb; 121(2):229-31. PubMed ID: 3977337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
    Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
    J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptors, acanthosis nigricans, and insulin resistance.
    Lancet; 1986 Mar; 1(8481):595-6. PubMed ID: 2869310
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lupus, insulin-resistant diabetes and acanthosis nigricans (author's transl)].
    Wechsler B; Michel JP; Molle D; Wechsler J; Franceschini P; Liozon F; Godeau P
    Ann Dermatol Venereol; 1981; 108(1):23-30. PubMed ID: 7235501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acanthosis nigricans, hypothyroidism, and insulin resistance.
    Matsuoka LY; Wortsman J; Gavin JR; Kupchella CE; Dietrich JG
    Am J Med; 1986 Jul; 81(1):58-62. PubMed ID: 3728554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin receptor and various disease entities].
    Kucharzewski M; Stanosek J; Czecior E
    Wiad Lek; 1985 Jun; 38(11):790-3. PubMed ID: 3901532
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of insulin resistance in subjects with acanthosis nigricans.
    Varthakavi PK; Patel KL; Wadhwa SL; Khopkar U; Sengupta RA; Merchant PC; Mehtalia SD; Nihalani KD
    J Assoc Physicians India; 2001 Jul; 49():705-12. PubMed ID: 11573555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin resistant diabetes, acanthosis nigricans and Bartter's syndrome, a fortuitous association?].
    Puel O; Massicot P; Taieb A; Seguin G; Foussier G; Guillard JM
    Arch Fr Pediatr; 1992 Apr; 49(4):361-3. PubMed ID: 1497426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The syndrome of insulin resistance, acanthosis nigricans and an autoimmune disorder in diabetes mellitus treated with immunosuppressants.
    Richards R; Morrison EY
    West Indian Med J; 1984 Sep; 33(3):195-7. PubMed ID: 6495719
    [No Abstract]   [Full Text] [Related]  

  • 13. Polypeptide hormones: pathology and clinical aspects.
    Van Obberghen E
    Acta Histochem Suppl; 1984; 29():51-5. PubMed ID: 6425926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin resistant diabetes showing anti-insulin receptor autoantibody with systemic scleroderma, acanthosis nigricans and total lipodystrophy (author's transl)].
    Sugawara H; Toyota T; Okuguchi F; Umezu M; Kai Y; Abe R; Maruhama Y; Goto Y; Hanew K; Utsumi N
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):361-9. PubMed ID: 7381285
    [No Abstract]   [Full Text] [Related]  

  • 15. [Physiologic and physiopathologic implications of insulin-receptor interaction (II). Pathologic situations in which changes in insulin-receptor interaction are detected].
    Durán García S; Hernández Herrero C
    Med Clin (Barc); 1984 Apr; 82(14):639-45. PubMed ID: 6376967
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for type 2 diabetes in children with acanthosis nigricans.
    Hardin DS
    Diabetes Educ; 2006; 32(4):547-52. PubMed ID: 16873592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of a primary (? genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans type A.
    Kahn CR; Podskalny JM
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1139-41. PubMed ID: 6989852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance).
    Moller DE; Flier JS
    N Engl J Med; 1988 Dec; 319(23):1526-9. PubMed ID: 2460770
    [No Abstract]   [Full Text] [Related]  

  • 19. Acanthosis nigricans, hyperinsulinaemia and risk factors for cardiovascular disease.
    Bener A; Lestringant GG; Nyomba BL; Frossard P; Saadi H
    East Mediterr Health J; 2000; 6(2-3):416-24. PubMed ID: 11556032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiologic and physiopathologic implications of insulin-receptor interaction (III)].
    Durán García S; González Mateo MC
    Med Clin (Barc); 1984 May; 82(17):771-6. PubMed ID: 6429461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.